abs

학술발표회초록보기

Inquiry on Abstract abstract@kcsnet.or.kr

Inquiry on Payment member@kcsnet.or.kr

현재 가능한 작업은 아래와 같습니다.
  • 01월 01일 09시 이후 : 초록수정 불가능, 일정확인 및 검색만 가능

Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression; Transcriptional induction of p21WAF1 and p27kip1 by inhibition of PI-3K/AKT pathway

Submission Date :
2 / 24 / 2006 , 17 : 51 : 22
Abstract Number :
97022412386
Presenting Type:
Symposium
Presenting Area :
의약화학 - 의약1. Development of Carbohydrate-Based Drugs
Authors :
김철호
성균관대학교 생명과학과,
Assigned Code :
금21E4심 Assigend Code Guideline
Presenting Time :
금 15시 : 30분

The simple ganglioside GM3 increases cyclin-dependent kinase (CDK) inhibitor (CKI) p21WAF1 expression through the accumulation of p53 protein by the PTEN-mediated inhibition of the PI-3K/AKT/MDM2 survival signaling in HCT116 colon cancer cells. GM3 induces p53-dependent transcriptional activity of p21WAF1, as evidenced by the p21WAF1 promoter-driven luciferase reporter plasmid (full-length p21WAF1 promoter and a construct lacking the p53 binding sites). Additionally, ganglioside GM3 enhanced expression of CKI p27kip1 through the PTEN-mediated inhibition of the PI-3K/AKT signaling. Furthermore, the down-regulation of the cyclin E and CDK2 was clearly observed in GM3-treated HCT116 cells, but the down-regulation of cyclin D1 and CDK4 was not. Whereas, suppression of PTEN levels by RNA interference restores the enhanced expression of p53-dependent p21WAF1 and p27 kip1 through inactivation of PTEN-mediated PI-3K/AKT signaling by ganglioside GM3. We conclude that GM3 represents a modulator of cancer cell proliferation and may have potential for use in colorectal cancer therapy.